These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 36685834)

  • 1. Recent advances in epigenetic anticancer therapeutics and future perspectives.
    Ren L; Yang Y; Li W; Yang H; Zhang Y; Ge B; Zhang S; Du G; Wang J
    Front Genet; 2022; 13():1085391. PubMed ID: 36685834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modifications in solid tumor metastasis in people of African ancestry.
    Oladipo EK; Olufemi SE; Adediran DA; Adejumo IO; Jimah EM; Oloke JK; Udekwu CC; Ogunwobi OO
    Front Oncol; 2024; 14():1325614. PubMed ID: 38450190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-Driven Strategies for Personalized Cancer Immunotherapy.
    Rocha GIY; Gomes JEM; Leite ML; da Cunha NB; Costa FF
    Cancer Manag Res; 2023; 15():1351-1367. PubMed ID: 38058537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update.
    Mondal P; Natesh J; Penta D; Meeran SM
    Semin Cancer Biol; 2022 Aug; 83():503-522. PubMed ID: 33309850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression.
    Wang D; Zhang Y; Li Q; Li Y; Li W; Zhang A; Xu J; Meng J; Tang L; Lyu S
    Genes Dis; 2024 Sep; 11(5):101020. PubMed ID: 38988323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance.
    Giardina SF; Valdambrini E; Warren JD; Barany F
    Curr Cancer Drug Targets; 2021; 21(4):306-325. PubMed ID: 33535953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia.
    Ramachandran S; Ient J; Göttgens EL; Krieg AJ; Hammond EM
    Genes (Basel); 2015 Sep; 6(4):935-56. PubMed ID: 26426056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer: epigenetics, drug resistance, and progression.
    Xie W; Sun H; Li X; Lin F; Wang Z; Wang X
    Cancer Cell Int; 2021 Aug; 21(1):434. PubMed ID: 34404407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?
    Farani MR; Sarlak M; Gholami A; Azaraian M; Binabaj MM; Kakavandi S; Tambuwala MM; Taheriazam A; Hashemi M; Ghasemi S
    Pathol Res Pract; 2023 Aug; 248():154688. PubMed ID: 37494800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
    Shukla S; Penta D; Mondal P; Meeran SM
    Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells.
    Mandhair HK; Novak U; Radpour R
    World J Stem Cells; 2021 Jun; 13(6):542-567. PubMed ID: 34249227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives.
    Sukocheva OA; Lukina E; Friedemann M; Menschikowski M; Hagelgans A; Aliev G
    Semin Cancer Biol; 2022 Jul; 82():35-59. PubMed ID: 33301860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer epigenetics: Past, present and future.
    Lee JE; Kim MY
    Semin Cancer Biol; 2022 Aug; 83():4-14. PubMed ID: 33798724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting epigenetics for cancer therapy.
    Park JW; Han JW
    Arch Pharm Res; 2019 Feb; 42(2):159-170. PubMed ID: 30806885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
    Bewersdorf JP; Shallis R; Stahl M; Zeidan AM
    Ther Adv Hematol; 2019; 10():2040620718816698. PubMed ID: 30719265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Epigenetics in the Development and Progression of Multiple Myeloma.
    Ismail NH; Mussa A; Zakaria NA; Al-Khreisat MJ; Zahidin MA; Ramli NN; Mohammad SNNA; Hassan R; Mohd Noor NH; Iberahim S; Zulkafli Z; Mohamed Yusoff S; Husin A; Johan MF
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of epigenetics in carcinogenesis: Recent advancements in anticancer therapy.
    Hussain S; Tulsyan S; Dar SA; Sisodiya S; Abiha U; Kumar R; Mishra BN; Haque S
    Semin Cancer Biol; 2022 Aug; 83():441-451. PubMed ID: 34182144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic control of gene expression: Potential implications for cancer treatment.
    Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
    Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.